Wolfe Research downgraded Amdocs (DOX) to Peer Perform from Outperform without a price target The firm says its near-term enthusiasm for the shares has “waned” since the company has sales growth acceleration or margin expansion embedded in its fiscal 2026 guidance. In addition, the T-Mobile commentary “heightens concerns, the analyst tells investors in a research note. Wolfe cites a lack of catalysts for the downgrade.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOX:
- Amdocs Hold Rating: Lack of Growth Catalysts and Concerns Over T-Mobile Impact
- Amdocs Limited’s Earnings Call: Growth and Challenges
- Amdocs Reports Q4 2025 Results and Strategic AI Investments
- Amdocs price target lowered to $97 from $100 at Stifel
- Amdocs price target lowered to $97 from $100 at BofA